Correlation Between Connect Biopharma and Zomedica Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Zomedica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Zomedica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Connect Biopharma Holdings and Zomedica Pharmaceuticals Corp, you can compare the effects of market volatilities on Connect Biopharma and Zomedica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Zomedica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Zomedica Pharmaceuticals.

Diversification Opportunities for Connect Biopharma and Zomedica Pharmaceuticals

-0.04

Correlation Coefficient

Connect Biopharma  Zomedica Pharmaceuticals

Good diversification

The 3 months correlation between Connect and Zomedica is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Zomedica Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zomedica Pharmaceuticals and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Zomedica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zomedica Pharmaceuticals has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Zomedica Pharmaceuticals go up and down completely randomly.

Pair Corralation between Connect Biopharma and Zomedica Pharmaceuticals

Given the investment horizon of 90 days Connect Biopharma Holdings is expected to under-perform the Zomedica Pharmaceuticals. In addition to that, Connect Biopharma is 1.2 times more volatile than Zomedica Pharmaceuticals Corp. It trades about -0.04 of its total potential returns per unit of risk. Zomedica Pharmaceuticals Corp is currently generating about 0.02 per unit of volatility. If you would invest  13.00  in Zomedica Pharmaceuticals Corp on September 3, 2024 and sell it today you would earn a total of  0.00  from holding Zomedica Pharmaceuticals Corp or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Connect Biopharma Holdings  vs.  Zomedica Pharmaceuticals Corp

Connect Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Connect Biopharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Zomedica Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Zomedica Pharmaceuticals Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Zomedica Pharmaceuticals is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Connect Biopharma and Zomedica Pharmaceuticals

The main advantage of trading using opposite Connect Biopharma and Zomedica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Zomedica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zomedica Pharmaceuticals will offset losses from the drop in Zomedica Pharmaceuticals' long position.

The idea behind Connect Biopharma Holdings and Zomedica Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.